Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Taysha Gene Therapies, Inc. | 1,317,389 | reported | 26 Jan 2026 | tx 34+4,908,880−1,572,245 |
| Solid Biosciences Inc. | 77,500 | reported | 12 Jun 2025 | tx 12+314,458 |
| AveXis, Inc. | 0 | reported | 15 May 2018 | tx 77+113,017−312,872 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jan 2026 | SALE | Taysha Gene Therapies, Inc. | 89,132 | 4.75 USD | |
| 26 Jan 2026 | SALE | Taysha Gene Therapies, Inc. | 26,918 | 4.61 USD | |
| 12 Jan 2026 | EXERCISE | Taysha Gene Therapies, Inc. | 88,676 | 1.71 USD | |
| 12 Jan 2026 | EXERCISE | Taysha Gene Therapies, Inc. | 111,324 | 0.70 USD | |
| 12 Jan 2026 | SALE | Taysha Gene Therapies, Inc. | 200,000 | 4.71 USD | |
| 12 Jan 2026 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 427,000 | 0.00 USD | |
| 12 Jan 2026 | EXERCISE | Taysha Gene Therapies, Inc. | 111,324 | 0.00 USD | deriv |
| 12 Jan 2026 | EXERCISE | Taysha Gene Therapies, Inc. | 88,676 | 0.00 USD | deriv |
| 12 Jan 2026 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 274,000 | 0.00 USD | deriv |
| 28 Nov 2025 | SALE | Taysha Gene Therapies, Inc. | 110,125 | 4.75 USD | |
| 28 Nov 2025 | EXERCISE | Taysha Gene Therapies, Inc. | 39,953 | 1.71 USD | |
| 28 Nov 2025 | EXERCISE | Taysha Gene Therapies, Inc. | 70,172 | 0.70 USD | |
| 01 Dec 2025 | SALE | Taysha Gene Therapies, Inc. | 260,047 | 4.51 USD | |
| 01 Dec 2025 | EXERCISE | Taysha Gene Therapies, Inc. | 260,047 | 1.71 USD | |
| 28 Nov 2025 | EXERCISE | Taysha Gene Therapies, Inc. | 70,172 | 0.00 USD | deriv |
| 28 Nov 2025 | EXERCISE | Taysha Gene Therapies, Inc. | 39,953 | 0.00 USD | deriv |
| 01 Dec 2025 | EXERCISE | Taysha Gene Therapies, Inc. | 260,047 | 0.00 USD | deriv |
| 10 Sept 2025 | EXERCISE | Taysha Gene Therapies, Inc. | 41,150 | 0.70 USD | |
| 10 Sept 2025 | SALE | Taysha Gene Therapies, Inc. | 200,000 | 3.23 USD | |
| 10 Sept 2025 | EXERCISE | Taysha Gene Therapies, Inc. | 41,150 | 0.00 USD | deriv |
| 21 Aug 2025 | SALE | Taysha Gene Therapies, Inc. | 57,054 | 2.85 USD | |
| 12 Jun 2025 | GRANT_AWARD | Solid Biosciences Inc. | 77,500 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 324,500 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 324,500 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | Solid Biosciences Inc. | 34,400 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 16 May 2023.